CeriBell, Inc. (CBLL) vs Odyssey Therapeutics, Inc. (ODTX)
A side-by-side comparison of CeriBell, Inc. and Odyssey Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.54HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
ODTX
Odyssey Therapeutics, Inc.
$19.74HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — CBLL vs ODTX
growth of $100 · dividends reinvested · last 1yCBLL +23.1% (+23.1%/yr)ODTX +26.9% (+26.9%/yr)ODTX compounded faster over this window
CBLL ODTX
CBLL vs ODTX: by the numbers
- •ODTX is the larger company ($948M vs $931M market cap).
- •Both run net losses; CBLL's is the smaller (-64.73% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | CBLL | ODTX |
|---|---|---|
| P/S ratio | 9.13 | N/A |
| P/B ratio | 7.26 | 2.25 |
Profitability
| Metric | CBLL | ODTX |
|---|---|---|
| Gross margin | 88.90% | 100.00% |
| Operating margin | -68.62% | -5415.19% |
| Net margin | -64.73% | -4994.86% |
| ROE | -51.43% | N/A |
| ROIC | -46.54% | -66.23% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.